Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
New Zealand
Fluticasone

PHARMAC

Fluticasone, Vilanterol

Breo Ellipta

Powder for inhalation 100 mcg with vilanterol 25 mcgNew ZealandFunded

Ask Osler about it

On this page

In other countries
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

Breo ElliptaCanada · 200 MCG / ACT + 25 MCG / ACT · Powder · Glaxosmithkline INCSame brand
Breo ElliptaCanada · 100 MCG / ACT + 25 MCG / ACT · Powder · Glaxosmithkline INCSame brand
Revinty Ellipta 184 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)Spain · 184 µg + 22 µg · polvo para inhalación (unidosis) · Glaxosmithkline Trading Services LimitedSame form
Revinty Ellipta 92 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)Spain · 92 µg + 22 µg · polvo para inhalación (unidosis) · Glaxosmithkline Trading Services LimitedSame form
Revinty Ellipta 92 Microgramos/22 Microgramos Polvo Para Inhalacion (Unidosis)Spain · 92 µg + 22 µg · polvo para inhalación (unidosis) · Glaxosmithkline Trading Services LimitedSame form
Relvar® Ellipta®

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Serbia · 22mcg+184mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. Beograd

Same form

🇷🇸Relvar® Ellipta®Serbia · 22mcg+92mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame form

🇷🇸Relvar® Ellipta®Serbia · 22mcg+92mcg · prašak za inhalaciju, podeljen · Evropa Lek Pharma D.O.O. BeogradSame form

🇸🇦RELVAR ELLIPTA 200/25 mcg inhalation powderSaudi Arabia · Glaxo OperationSame form

🇪🇺Relvar ElliptaEuropean Union · GlaxoSmithKline Trading Services LimitedSame substance

🇪🇺Revinty ElliptaEuropean Union · GlaxoSmithKline Trading Services LimitedSame substance

🇸🇦Relvar ElliptaSaudi Arabia · Glaxo OperationSame substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

PHARMAC, New Zealand

New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/schedule/archive/Schedule_2026-10.xml; October 2026; published 2026-10-08; acquired 2026-10-13T22:49:29.739475+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.

Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Fluticasone, Vilanterol
Dosage form: Powder for inhalation 100 mcg with vilanterol 25 mcg
Register: New Zealand (PHARMAC)
Status: Funded
Status in the register: Funded by PHARMAC
Procedure: Community Pharmaceutical Schedule
Supply: Funded (PHARMAC)